A popular antidepressant, often known by the brand name Cymbalta, was recalled last week due to the presence of a potentially cancer-causing chemical. More than 233,000 bottles of duloxetine capsules ...

Over 7,100 bottles of Duloxetine were voluntarily recalled by the medication's company beginning Oct. 10 Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her work ...

Gradually taper off Cymbalta with help from your healthcare provider to avoid severe withdrawal symptoms. Stopping Cymbalta suddenly can cause symptoms like dizziness, nausea, and trouble sleeping.

Duloxetine is the first drug to gain FDA approval for the indication of diabetic peripheral neuropathic pain. However, randomized controlled clinical trials of duloxetine for this indication have not ...

The Food and Drug Administration (FDA) has announced a significant recall affecting over 550,000 bottles of duloxetine delayed-release capsules. This recall comes as a result of elevated levels of a ...

Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic pain. A recent Food and Drug Administration (FDA) recall of a commonly ...

Review the side-effects of Duloxetine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Patients treated with neurotoxic forms of chemotherapy are often left with a painful peripheral neuropathy that persists long after treatment of their cancer has concluded. A variety of drugs have ...

In August 2004, duloxetine hydrochloride (Cymbalta; Eli Lilly), a selective serotonin- and noradrenaline-reuptake inhibitor, was approved by the US FDA for the treatment of major depressive disorder.

More than 233,000 bottles of an antidepressant have been recalled by public health officials due to a chemical containing the risk of cancer. The U.S. Food and Drug Administration classified capsules ...

The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain cancer-causing chemicals. Gidget writes for the latest news section of AS ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Duloxetine Sales, Price Analysis, & Sales Forecast - 2017" report to their offering. Find out the sales of Duloxetine ...